MYLUNG Consortium Part 3: Observational Study

Part of paid clinical trials in Daphne, Alabama.

Sponsor
US Oncology Research
Study ID
NCT05885698
Status
Recruiting
Apply to this trial

Conditions

  • Carcinoma, Non-Small-Cell Lung

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This longitudinal study looks to quantify the testing timeline, operational barriers, and outcomes of biomarker-guided therapy in a large, community-based, and largely unselected patient population with early stage and advanced stage, treatment-naive non-small cell lung cancer, whether squamous or non-squamous.

Key Dates

First listed
Jun 2, 2023
Start date
Jan 30, 2023
Status verified
May 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
7,500 participants (estimated)

Arms

  • Arm: Non-small Cell Lung Cancer

Primary Outcome Measure

Proportion of Patients Who Receive Biomarker Test Results Prior to Systemic Therapy or Death [ Time Frame: 5 years from date of enrollment into study ]

Central Contacts

Locations (17)

FacilityCityStateZIPSite coordinators
Southern Cancer Center, PCDaphneAlabama36526
Karla Childers
[email protected]
251-433-9899
Michael Meshad, MD (PRINCIPAL_INVESTIGATOR)
Arizona Oncology Associates, PC - NAHOAPrescott ValleyArizona86314
Erika Arguello Vargas
[email protected]
928-775-9430
Allan V. Espinosa Morazan, MD (PRINCIPAL_INVESTIGATOR)
Rocky Mountain Cancer CenterDenverColorado80218-
Cancer Care Centers of Brevard, Inc.Palm BayFlorida32901
Karla Childers
[email protected]
251-433-9899
Venkat Pavan R. Kancharla, MD (PRINCIPAL_INVESTIGATOR)
Woodlands Medical Specialists, PAPensacolaFlorida32503-
Affiliated Oncologists, LLCChicago RidgeIllinois60415
Angela Malone
[email protected]
708-424-9710
Rami Y. Haddad, MD (PRINCIPAL_INVESTIGATOR)
Illinois Cancer SpecialistsNilesIllinois60714-
Maryland Oncology Hematology, P.A.Silver SpringMaryland20904-
Minnesota Oncology Hematology, P.A.MinneapolisMinnesota55404-
New York Oncology Hematology, P.C.AlbanyNew York12208
Ambri Cicchinelli
[email protected]
518-262-6696
Makenzi Evangelist, MD (PRINCIPAL_INVESTIGATOR)
Oncology Hematology Care Clinical Trials, LLCCincinnatiOhio45242
Sara Gonce
[email protected]
513-751-2273
Patrick J. Ward, MD (PRINCIPAL_INVESTIGATOR)
Willamette Valley Cancer Institute and Research CenterEugeneOregon97401
Jeanne Schaffer
[email protected]
541-683-5001
James E. Butrynski, MD (PRINCIPAL_INVESTIGATOR)
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer CareBlacksburgVirginia24060
Natasha R. Holt
[email protected]
540-982-0237
Jerome H. Goldschmidt, Jr., MD (PRINCIPAL_INVESTIGATOR)
Virginia Cancer Specialists, PCFairfaxVirginia22031-
Virginia Oncology AssociatesNewport NewsVirginia23606
Ebony Villarson
[email protected]
757-873-9810
John C. Paschold, MD (PRINCIPAL_INVESTIGATOR)
Shenandoah Oncology, P.C.WinchesterVirginia22601-
Northwest Cancer Specialists, P.C.VancouverWashington98684
Julian Kern
[email protected]
360-597-1300
Anthony Van Ho, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Daphne, AL

By research site
Southern Cancer Center, PC· Daphne, ALArizona Oncology Associates, PC - NAHOA· Prescott Valley, AZRocky Mountain Cancer Center· Denver, COCancer Care Centers of Brevard, Inc.· Palm Bay, FLWoodlands Medical Specialists, PA· Pensacola, FLAffiliated Oncologists, LLC· Chicago Ridge, IL

Related Studies